Trials / Suspended
SuspendedNCT02465008
Analgesic Effect of Levobupivacaine in Breast Augmentation
Analgesic Efficacy of Levobupivacaine Administration in Periprosthetic Breast Augmentation With Implants
- Status
- Suspended
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 66 (estimated)
- Sponsor
- General University Hospital of Valencia · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether levobupivacaine is effective in the acute postoperative pain treatment in periprosthetic breast augmentation
Detailed description
One of the most common plastic surgery is breast augmentation using prosthesis ( mammoplasty Surgery with cohesive silicone gel prosthesis insubpectoral plane). Remains challenging management of acute postoperative pain that allows for early discharge of patients. To this end the following objectives are proposed: evaluate the analgesic efficacy of L-Bupivacaine 0.25% vs. Placebo (saline) administered irrigation into the surgical pocket bilaterally intraoperatively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levobupivacaine | |
| DRUG | Placebo |
Timeline
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2015-06-08
- Last updated
- 2016-07-20
Source: ClinicalTrials.gov record NCT02465008. Inclusion in this directory is not an endorsement.